Potential game changer for treatment and containment
A new test can accurately diagnose Ebola virus disease within minutes, providing clinicians with crucial information for treating patients and containing outbreaks.
Researchers from Harvard Medical School, Partners In Health and Boston Children’s Hospital have shown that a new commercially developed rapid diagnostic test performed at bedside was as sensitive as the conventional laboratory-based method used for clinical testing during the recent outbreak in Sierra Leone. The results are published in The Lancet.
While the West African Ebola epidemic has slowed since its peak last fall, the crisis simmers on; there were still 24 confirmed cases of Ebola reported in Guinea and Sierra Leone in the week ending June 14.
To fight Ebola, the first step is to determine which patients are sick with the disease and which with other illnesses with a similar presentation. To use the currently recommended molecular approach, laboratories must be built and samples of highly infectious blood must be drawn, often with unsafe needles and syringes, and then shipped over potentially great distances at substantial risk to the health care workers involved in the process. Then, clinicians and patients must wait for results–sometimes for several days.
These obstacles and delays prevent timely diagnosis and treatment, and also result in individuals without Ebola being admitted to holding units where they may become infected with the virus, the researchers said.
“Simplifying the process and speeding up diagnosis could have a major impact,” said Nira Pollock, senior author of the paper and HMS assistant professor of medicine and associate medical director of the Infectious Diseases Diagnostic Laboratory at Boston Children’s Hospital.
As the Ebola outbreak in West Africa began to surge in 2014, Pollock and Partners In Health researcher Jana Broadhurst worked with the research core of the HMS Department of Global Health and Social Medicine to reach out to teams around the world who were developing diagnostic tools that would enable clinicians to diagnose Ebola patients quickly.
One candidate, the ReEBOV Antigen Rapid Test, developed by Corgenix, seemed like a promising tool. Working with colleagues at Partners In Health and the Ministry of Health and Sanitation in Sierra Leone, the HMS team was able to plug into an environment that allowed it to train local technicians to perform the test and help collect data for the study. The team at the Public Health England lab at Port Loko, where clinical samples were routinely sent for standard molecular diagnostic testing, were also key collaborators. Corgenix donated test kits to the HMS team.
The field trial took place at two treatment centers operated by the Ministry of Health and Sanitation of Sierra Leone and supported by PIH, where 106 patients suspected of having Ebola were tested during February 2015 using the rapid diagnostic test (performed on a fingerstick blood sample at the point of care). The patients were also tested using the standard RT-PCR (performed on plasma in the laboratory). Both rapid diagnostic tests, on whole blood, and RT-PCR, on plasma, were also performed on 284 samples in the laboratory.
The rapid diagnostic test detected all confirmed cases of Ebola that were positive by the benchmark test in both point-of-care and laboratory testing with sensitivity of 100 percent (identifying all patients with Ebola found by the benchmark method), and a specificity of 92 percent (few false positives).
Surprisingly, the study also showed that the standard RT-PCR test, under the conditions deployed in the field, was itself an imperfect reference standard.
Both tests failed to detect a small number of Ebola cases that had been detected by an alternative lab test that was more sensitive than the benchmark test but was not available for wide usage. All of the missed cases showed very low levels of virus. The authors caution that given the limitations of the performance of the benchmark RT-PCR reference test in patients with low levels of the virus, more research is needed to assess how the new rapid diagnostic test will perform in patients still in the early stages of Ebola virus disease.
Read more:Â Rapid Ebola diagnostic successful in field trial
The Latest on: Rapid Ebola diagnostic
via Google News
The Latest on: Rapid Ebola diagnostic
- Monkeypox: When to get tested and what to do if you're exposedon August 1, 2022 at 1:09 pm
Past outbreaks of influenza A, Ebola, Zika ... or antigens (e.g., lateral flow and/or rapid antigen testing) are of limited value for monkeypox diagnosis because the virus demonstrates significant ...
- US Boosts Health Service in Lagos, Donates States-of- the Art Laboratoryon July 27, 2022 at 5:00 pm
Prompt diagnosis and clinical management ... in Nigeria during the 2014 Ebola outbreak and worked with Nigerian health authorities for the rapid and successful containment of the disease.
- Marburg Virus Disease: What to Knowon July 27, 2022 at 5:00 pm
Marburg has caused fewer outbreaks than Ebola as of late 2020. Doctors have rapid tests to diagnose Ebola. Researchers are still working on creating rapid tests for Marburg. There isn’t an FDA ...
- Advancing Rapid Point-of-care Viral Diagnostics to a Clinical Settingon July 26, 2022 at 5:00 pm
The example of the western Africa Ebola outbreak highlights two important ... leading to better outcomes and reduced drug resistance. RDT: Rapid diagnostic test.
- Surveillance and Preparedness for Ebola Virus Disease — New York City, 2014on July 25, 2022 at 5:00 pm
The recent diagnosis of Ebola in a person in the United States ... preparedness capacity in the local health care system, and rapid, frequent and responsive communication with the health care ...
- ‘UMT Removes Guesswork from Malaria Testing’on July 24, 2022 at 5:00 pm
In Ebola outbreak situations (which also has ... when a company called Becton Dickinson first introduced the blood Rapid Diagnostic Test (RDT). The third major global milestone in malaria ...
- Whispering gallery mode device offers rapid Ebola diagnosison July 21, 2022 at 3:16 am
This protein is also key to current diagnostic tests for Ebola — but the new antibody is capable of ... the medical care they need and breaking the cycle of transmission.” “Rapid, biosensor-based ...
- Fatal Marburg Virus Claims Two Lives: Critical Symptoms Of The Disease To Knowon July 20, 2022 at 4:03 am
The new disease, Marburg virus disease (MVD) is now spreading at a rapid rate ... as Lassa fever or Ebola). As per reports, it can be challenging to make a clinical diagnosis of Marburg virus ...
- What Is Marburg? What You Need To Know About The Deadly Virus Detected In Ghanaon July 18, 2022 at 8:41 am
Ghana confirmed the country’s first outbreak of the deadly Marburg virus on Sunday, placing it and neighboring countries on high alert as experts scramble to contain the highly infectious Ebola ...
- Did SARS Prepare East Asia for Ebola?on July 15, 2022 at 5:00 pm
The reported rapid rate of infection has been ... typhoid fever and meningitis, effective diagnosis has proven to be a tough challenge. The Ebola outbreak has also seen an alarming feature of ...
via Bing News